REGORAFENIB

Clinical trials for REGORAFENIB explained in plain language.

Never miss a new study

Get alerted when new REGORAFENIB trials appear

Sign up with your email to follow new studies for REGORAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug duo aims to hunt down Cancer's last traces

Disease control Terminated

This study is testing whether a combination of two drugs, regorafenib and lorigerlimab, can clear tiny traces of cancer left in the blood after standard treatment for colorectal cancer. The goal is to see if this treatment can prevent the cancer from coming back in patients who s…

Matched conditions: REGORAFENIB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

REGORAFENIB

Get alerted when new REGORAFENIB trials appear

New drug duo aims to hunt down Cancer's last traces